Parameter
| Biomarker | PD-L1 | Full name | Programmed death-ligand 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | Immunotherapy Prediction |
| Disease | Thyroid Cancer | Disease Subtypes | / | ||
| Organ | Thyroid | Test Sample / Technology Platform | Organization (IHC) | ||
| Pathobiological Mechanisms | Inhibition of T cell activity, and promote the tumor immune escape | ||||
| Clinical Availability Status | Clinical research: in the ATC/PDTC high expression, prompt immunotherapy potential benefit | ||||
| Notes and Dynamics | Combination with tumor mutational burden can optimize immunotherapy screening | ||||